(Q34174220)

English

Preventing dementia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Preventing dementia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

author name string

Black SE

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Patterson C

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Feightner J

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Canadian Journal of Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

28 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

S56-66

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Anti-inflammatory drugs in the fight against Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

The "protective" influence of cigarette smoking on Alzheimer's and Parkinson's diseases. Quagmire or opportunity for neuroepidemiology?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Further thoughts on the aluminum-Alzheimer's disease link

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Aluminum concentrations in drinking water and risk of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Herpes simplex virus type 1 in brain and risk of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

The association between head trauma and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Influence of education and occupation on the incidence of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Epidemiology, education, and the ecology of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Alzheimer's disease in Down's syndrome: clinicopathologic studies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Apolipoprotein E type 4 allele and Alzheimer's disease: effect on age at onset and relative risk in different age groups.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Genetic factors for the development of Alzheimer disease in the Cherokee Indian.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Hippocampal formation size predicts declining memory performance in normal aging

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

A typology of sub-clinical senescent cognitive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Genetic factors in Alzheimer's disease: a review of recent advances

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Genes and recent developments in the epidemiology of Alzheimer's disease and related dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Clinical trials in dementia with propentofylline

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Overview of clinical trials of hydergine in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Effects of estrogen on memory function in surgically menopausal women

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogenic effects on memory in women

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Sex hormones and psychological functioning in postmenopausal women

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Lack of postmenopausal estrogen replacement therapy and the risk of dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

CT in the differential diagnosis between Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Presence and treatment of vascular risk factors in patients with vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Antihypertensive drugs, brain structure, and cognitive function: more research is necessary.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Aetiological considerations and risk factors for multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Status of risk factors for dementia associated with stroke

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

The effect on memory of chronic prednisone treatment in patients with systemic disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Smoking and Alzheimer's disease: a review of the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

European Pentoxifylline Multi-Infarct Dementia Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

21 January 2018

Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin E and Alzheimer disease: the basis for additional clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunocytochemistry of neurofibrillary tangles in dementia pugilistica and Alzheimer's disease: evidence for common genesis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Tobacco consumption and cognitive impairment in elderly people. A population-based study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of Alzheimer disease in intellectual disability: results and recommendations from an international conference

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of exposure of miners to aluminium powder

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

The Canadian Study of Health and Aging: risk factors for vascular dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease: longitudinal CT studies of ventricular change.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of cognitive change in older persons: MacArthur studies of successful aging.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001219

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0317167100001219

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34174220&oldid=2041979254"